| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF9301-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77044-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB21291-SP | |||
| Carrier Free | FAB21291V-100UG | |||
| Carrier Free | FAB21291U-100UG | |||
| Carrier Free | FAB21291T-100UG | |||
| Carrier Free | FAB21291S-100UG | |||
| Carrier Free | FAB21291R-100UG | |||
| Carrier Free | FAB21291N-100UG | |||
| Carrier Free | FAB21291G-100UG | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB930U-100UG | |||
| Alexa Fluor 405 | FAB930V-100UG | |||
| Alexa Fluor 488 | FAB930G-100UG | |||
| Alexa Fluor 532 | FAB930X-100UG | |||
| Alexa Fluor 594 | FAB930T-100UG | |||
| Alexa Fluor 647 | FAB930R-100UG | |||
| Alexa Fluor 700 | FAB930N-100UG | |||
| Alexa Fluor 750 | FAB930S-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB930-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2129-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-58422-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26523-50ul | |||
![N/A TACE/ADAM17 [Biotin]](http://images.novusbio.com/fullsize2/DATA_TACE_DY930_ELISA_2267.jpg "N/A TACE/ADAM17 [Biotin]")
![Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with ADAM17 antibody [C2C3], C-term diluted at 1:500.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP2-15281-img0005.jpg "Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with ADAM17 antibody [C2C3], C-term diluted at 1:500.")
![Immunohistochemistry-Paraffin: TACE/ADAM17 Antibody [NBP2-15281] - Human breast carcinoma dilution: 1:250. ADAM17 antibody [C2C3], C-term dilution: 1:250. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Immunohistochemistry-Paraffin-NBP2-15281-img0006.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - 30 ug K562 whole cell lysate/extract, 7.5% SDS-PAGE gel, dilution 1:500.](http://images.novusbio.com/fullsize/ADAM17-Antibody-Western-Blot-NBP2-15281-img0001.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with ADAM17 antibody [C2C3], C-term diluted at 1:500.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP2-15281-img0004.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with TACE/ADAM17 antibody [C2C3], C-term (NBP2-15281) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/nbp2-15281_rabbit-polyclonal-tace-adam17-antibody-91020242014683.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: TACE/ADAM17 Antibody [NBP2-15281] - Wild-type (WT) and ADAM17 knockout (KO) HeLa (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with ADAM17 antibody [C2C3], C-term diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-15281_rabbit-polyclonal-tace-adam17-antibody-1610202419414541.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP1-77044] - KO Validation in HeLa Cells. Loading: 10 ug of HeLa WT cell lysates or TACE KO celllysates. Antibodies: TACE/ADAM17 NBP1-77044 (0.25 ug/mL) and beta-actin NBP1-76692 (1 ug/mL), 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP1-77044-img0008.jpg "<b>Genetic Strategies Validation. </b>Western Blot: TACE/ADAM17 Antibody [NBP1-77044] - KO Validation in HeLa Cells. Loading: 10 ug of HeLa WT cell lysates or TACE KO celllysates. Antibodies: TACE/ADAM17 NBP1-77044 (0.25 ug/mL) and beta-actin NBP1-76692 (1 ug/mL), 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.")
![<b>Genetic Strategies Validation. </b>Western Blot: TACE/ADAM17 Antibody [NBP1-77044] - HeLa whole cell lysate. Image from verified customer review.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP1-77044-img0003.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP1-77044] - Analysis of TACE in HeLa (A, D), Jurkat (B, E) and Raji (C,F) cell lysate in (A-C) the absence or (D-F) the presence of blocking peptide with TACE antibody at 0.5 ug/mL.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP1-77044-img0006.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: TACE/ADAM17 Antibody [NBP1-77044] - IAV via Protein Expression Profile in Cells Lines. Antibodies: TACE and GAPDH. Secondary: Goat anti-rabbit IgG HRP conjugate.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP1-77044-img0007.jpg)
![Immunocytochemistry/ Immunofluorescence: TACE/ADAM17 Antibody - BSA Free [NBP1-77044] - Figure 5 Immunocytochemistry Validation of TACE/ADAM17 in HeLa CellsImmunohistochemical analysis of HeLa cells using anti-TACE/ADAM17 antibody at 10 u/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-77044_rabbit-polyclonal-tace-adam17-antibody-2711202419201577.jpg)
![Immunocytochemistry/ Immunofluorescence: TACE/ADAM17 Antibody - BSA Free [NBP1-77044] - Figure 4 Immunofluorescence Validation of TACE/ADAM17 in HeLa CellsImmunofluorescent analysis of 4% paraformaldehyde-fixed HeLa cells labeling TACE/ADAM17 with at 10 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green).](http://images.novusbio.com/fullsize/nbp1-77044_rabbit-polyclonal-tace-adam17-antibody-271120242045673.jpg)
![Western Blot: TACE/ADAM17 Antibody [NBP2-58422] - Analysis in human cell line RT-4 and human cell line U-251 MG.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Western-Blot-NBP2-58422-img0002.jpg "Western Blot: TACE/ADAM17 Antibody [NBP2-58422] - Analysis in human cell line RT-4 and human cell line U-251 MG.")
![Immunocytochemistry/Immunofluorescence: TACE/ADAM17 Antibody [NBP2-58422] - Staining of human cell line U-251 MG shows localization to cytosol.](http://images.novusbio.com/fullsize/TACE-ADAM17-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-58422-img0001.jpg)
![ELISA: Rat TACE/ADAM17 ELISA Kit (Colorimetric) [NBP3-08179] - Samples were spiked with high concentrations of Rat TACE/ADAM17 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp3-08179_rat-tace-adam17-elisa-kit-colorimetric-13220241685381.jpg "ELISA: Rat TACE/ADAM17 ELISA Kit (Colorimetric) [NBP3-08179] - Samples were spiked with high concentrations of Rat TACE/ADAM17 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Rat TACE/ADAM17 ELISA Kit (Colorimetric) [NBP3-08179] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-08179_rat-tace-adam17-elisa-kit-colorimetric-432024983517.jpg)
![Immunocytochemistry/Immunofluorescence: TACE/ADAM17 Antibody (5A1) [NBP3-26523] - Staining of Hela Cells with TACE/ADAM17 Antibody (5A1) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeated by 0.2% Triton X-100, and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26523_rabbit-tace-adam17-mab-5a1-282202412493618.jpg "Immunocytochemistry/Immunofluorescence: TACE/ADAM17 Antibody (5A1) [NBP3-26523] - Staining of Hela Cells with TACE/ADAM17 Antibody (5A1) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeated by 0.2% Triton X-100, and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).")
![Western Blot: ADAM17 Peptide [NBP1-77044PEP] - TACE peptide is used for blocking the activity of Anti-TACE. Incubating the peptide with equal volume of antibody for 30 min at 37C usually completely blocks the activity of Anti-TACE in Western blotting.](http://images.novusbio.com/fullsize/ADAM17-Peptide-Western-Blot-NBP1-77044PEP-img0001.jpg "Western Blot: ADAM17 Peptide [NBP1-77044PEP] - TACE peptide is used for blocking the activity of Anti-TACE. Incubating the peptide with equal volume of antibody for 30 min at 37C usually completely blocks the activity of Anti-TACE in Western blotting.")